The distribution of the molecularly defined breast cancer subtypes was as follows: ER positive (69.5%, n = 362), HER2 positive (16.3%, n = 85), and TNBC (14.2%, n = 75) (Online Resource 2). This evidence concerns the gene ESR1 and breast carcinoma.